Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients.
about
Spironolactone for hypertensionMineralocorticoid receptor blockade in chronic kidney diseaseMineralocorticoid Receptor Antagonism for Cardiovascular Protection in End-Stage Renal Disease: New Data But the Controversy Continues.Disordered aldosterone-volume relationship in end-stage kidney disease.A randomized, double-blind, placebo-controlled trial of spironolactone on carotid intima-media thickness in nondiabetic hemodialysis patientsAntihypertensive agents in hemodialysis patients: a current perspective.Role of the kidneys in resistant hypertensionManagement of Resistant Hypertension: Do Not Give Up on Medication.Mineralocorticoid receptor antagonists as diuretics: Can congestive heart failure learn from liver failure?Mineralocorticoid receptor blockade-a novel approach to fight hyperkalaemia in chronic kidney diseaseThe Safety of Eplerenone in Hemodialysis Patients: A Noninferiority Randomized Controlled TrialClinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis.Mineralocorticoid receptor blockade in chronic kidney disease.Targeting the renin angiotensin system in dialysis patients.Evaluation and pharmacologic approach to patients with resistant hypertension.Safety of mineralocorticoid receptor antagonists in patients receiving hemodialysis.Mineralocorticoid receptor antagonists: their use and differentiation in Japan.How is the heart best protected in chronic dialysis patients?: Is there life in the old drugs yet? Mineralocorticoid receptor antagonism for cardiovascular prevention in chronic dialysis patients.Low dialysate potassium concentration: an overrated risk factor for cardiac arrhythmia?Clinical Outcomes in Dialysis Patients: Prospects for Improvement with Aldosterone Receptor Antagonists.Safety and cardiovascular effects of mineralocorticoid receptor antagonists for patients receiving hemodialysis: a systematic review and meta-analysis.Pharmacotherapy of Hypertension in Chronic Dialysis Patients.Mineralocorticoid Receptor Blockade in End-Stage Renal Disease.Is it time for spironolactone therapy in dialysis patients?Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients.Complete remission of hypertension in a hemodialysis patient after adrenalectomy for primary aldosteronism and renal transplantation.
P2860
Q24236324-AD3EEED1-9350-44A3-860F-429F3D70BA70Q26864370-081450D6-C245-41ED-A447-D10D57CB044AQ31004378-9234F228-6899-4B07-8B49-445255F2BF18Q33764028-B168810D-960A-4397-88AB-C9F6E6316A4DQ34075463-7EC4773E-47B1-4099-9937-F833D1F6E794Q34700870-235D7F30-53B9-47FD-AF53-3E359F325E64Q34725369-33B6B3F9-C7BD-4D76-8335-042A545A7C2DQ35026633-9B85ABDD-FDAB-4616-80A9-4508AE1695B6Q35272248-F1390484-7A0A-4516-98E3-F6E8E91D1C5FQ35626544-0DFA4F16-7DB4-4BA1-8AD8-944A9FFD3156Q36025666-02A53A99-EEA9-47C4-AEEC-A99D71B1350BQ37620992-27BAF5E9-B94D-420D-9FCB-CA83934A455DQ37861583-F79A71EC-B984-4219-8093-9FE49702BD1CQ37891151-46049B54-76AF-4AEC-A8A0-E5A17D52B3CBQ37982211-07B5CACB-DDF9-4CC0-B7C0-A58FEE53B6B5Q38016388-F3B180B8-3AFA-4DF6-AF5A-C333FEA6299CQ38061551-C03F44D9-AC27-4B36-9FEA-AE0226733BB6Q38185467-0D97A798-8E82-4CE9-9FFF-D112746183F1Q38285588-DD59E822-9903-40DD-896B-60A8A73B3B2AQ38560705-23CE0A8B-1939-4138-BD73-B8C4C191DBB4Q38746216-AF00B3BB-C517-4BCB-932E-FC56D02B19D2Q38802032-D67B6605-75E6-43E3-ADF1-AD7F911ADC9CQ38815486-44E366E0-FA76-4FEC-BC0F-34CD6AC8B849Q46921303-53298275-325D-4446-B0D2-8C7B7244B7B9Q47134104-D5EA8D01-E6BF-4B26-AF38-B886D310C5D3Q49484949-702F6B3E-FCFE-4FB6-8392-D31EBEE37412
P2860
Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Effect of spironolactone on bl ...... -anuric hemodialysis patients.
@en
Effect of spironolactone on bl ...... -anuric hemodialysis patients.
@nl
type
label
Effect of spironolactone on bl ...... -anuric hemodialysis patients.
@en
Effect of spironolactone on bl ...... -anuric hemodialysis patients.
@nl
prefLabel
Effect of spironolactone on bl ...... -anuric hemodialysis patients.
@en
Effect of spironolactone on bl ...... -anuric hemodialysis patients.
@nl
P2093
P1476
Effect of spironolactone on bl ...... -anuric hemodialysis patients.
@en
P2093
Evan Gross
Henrikas Irmantas Juknis
Marcos Rothstein
Susan Dombek
P304
P356
10.1053/J.AJKD.2005.03.005
P577
2005-07-01T00:00:00Z